Instrument Inactif

Cours Ocata Therapeutics Inc OTC Bulletin Board

Actions

Cours en clôture OTC Bulletin Board Autres places de cotation
- ^USD	-

Ocata Therapeutics : Astellas Announces Results of Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics and Changes to Subsidiaries	10/02/16
Ocata Therapeutics : Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics	22/01/16
Ocata Therapeutics : Reports the Publication of Data about the Generation of Corneal Endothelial Cells from Human Pluripotent Stem Cells	28/12/15
Ocata Therapeutics : Hemangio-derived Mesenchymal Cells Preserve Kidney Function and Extend Lifespan in Preclinical Model of Lupus Nephritis	03/12/15
OCATA THERAPEUTICS : Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with Astellas Pharma Inc.	11/11/15

Dirigeants	Titre	Age	Depuis
Yoshitsuga Shitaka PSD	President	-	-
John Heffernan PRN	Corporate Officer/Principal	-	03/02/15

Administrateurs	Titre	Age	Depuis
Percival Barretto-Ko BRD	Director/Board Member	51	-
Masaaki Hirano BRD	Director/Board Member	57	-
Toru Yoshimitsu BRD	Director/Board Member	61	-

Secteur

	Varia. 1 janv.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+7,30%	113 Md
REGENERON PHARMACEUTICALS, INC.	+11,01%	106 Md
ARGENX SE	+0,87%	22,27 Md
BIONTECH SE	-12,31%	22,22 Md
GENMAB A/S	-5,52%	19,43 Md
WUXI APPTEC CO., LTD.	-37,85%	17,87 Md
BEIGENE, LTD.	-5,99%	17,24 Md
NEUROCRINE BIOSCIENCES, INC.	+7,05%	14,29 Md
SAREPTA THERAPEUTICS, INC.	+34,83%	12,52 Md